Fidelity

Total investments

87

Average round size

325M

Portfolio companies

75

Rounds per year

1.12

Lead investments

20

Follow on index

0.11

Exits

34

Stages of investment
Private EquityLate Stage Venture
Areas of investment
BiotechnologyE-CommerceSoftwareRetailAnalyticsHealth CareMobile AppsManufacturingMedicalConsumer Electronics

Investments analytics

Analytics

Total investments
87
Lead investments
20
Exits
34
Rounds per year
1.12
Follow on index
0.11
Investments by industry
  • Biotechnology (14)
  • Health Care (12)
  • Software (12)
  • Mobile Apps (9)
  • E-Commerce (8)
  • Show 134 more
Investments by region
  • United States (53)
  • India (11)
  • China (2)
  • Canada (6)
  • Germany (2)
  • Show 7 more
Peak activity year
2015
Number of Unicorns
22
Number of Decacorns
33
Number of Minotaurs
25

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.

Quantitative data

Avg. startup age at the time of investment
13
Avg. valuation at time of investment
5B
Group Appearance index
0.99
Avg. company exit year
10
Avg. multiplicator
4.40
Strategy success index
1.00

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Latest deals

Company name Deal date Industry Deal stage Deal size Location
Bright Peak Therapeutics 11 Jun 2024 Biotechnology, Therapeutics Late Stage Venture 90M Switzerland, Basel-City, Basel
Chenjing Tech 09 Feb 2022 Early Stage Venture
ITBegin 17 Jan 2018 Internet, E-Learning, Training Seed 463K Zhejiang, Shangcheng District, China
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.